{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.07","upperLimit":"6.18","value":"0.69"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"description":"Summarized by Kaplan-Meier methods including 90% confidence intervals for the median using method of Brookmeyer and Crowley. Time until progression, death or last evaluation will be calculated. If a patient did not progress or die, they will be censored at their last evaluation in the analysis.","dispersionType":"90% Confidence Interval","groups":[{"description":"Patients receive palifosfamide IV over 30 minutes on days 1-3. Treatment repeats every 21 days for up to 6 courses in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Treatment (Palifosfamide)"}],"paramType":"MEDIAN","populationDescription":"All patients who enrolled and received treatment.","reportingStatus":"POSTED","timeFrame":"Up to 2 years","title":"Progression Free Survival (PFS)","type":"SECONDARY","unitOfMeasure":"months"}